Citations (183)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Simone Garzon, Antonio Simone Laganà, Fabio Barra, Jvan Casarin, Antonella Cromi, Ricciarda Raffaelli, Stefano Uccella, Massimo Franchi, Fabio Ghezzi & Simone Ferrero. (2020) Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development. Expert Opinion on Investigational Drugs 29:12, pages 1377-1388.
Read now
Read now
Yuan Sun, Xiaomin Lou, Min Yang, Chengfu Yuan, Ling Ma, Bing-Kun Xie, Jian-min Wu, Wei Yang, Xiang Jun Shen, Ningzhi Xu & D. Joshua Liao. (2013) Cyclin-dependent kinase 4 may be expressed as multiple proteins and have functions that are independent of binding to CCND and RB and occur at the S and G2/M phases of the cell cycle. Cell Cycle 12:22, pages 3512-3525.
Read now
Read now
C. Elizabeth Caldon, C. Marcelo Sergio, Judith Schütte, Marijke N. Boersma, Robert L. Sutherland, Jason S. Carroll & Elizabeth A. Musgrove. (2009) Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc. Molecular and Cellular Biology 29:17, pages 4623-4639.
Read now
Read now
Asmaà Fritah, Cécile Saucier, Jan Mester, Gérard Redeuilh & Michèle Sabbah. (2005) p21/ Selectively Controls the Transcriptional Activity of Estrogen Receptor α. Molecular and Cellular Biology 25:6, pages 2419-2430.
Read now
Read now
Maggie C. Louie, June X. Zou, Alina Rabinovich & Hong-Wu Chen. (2004) ACTR/AIB1 Functions as an E2F1 Coactivator To Promote Breast Cancer Cell Proliferation and Antiestrogen Resistance. Molecular and Cellular Biology 24:12, pages 5157-5171.
Read now
Read now
James S. Foster, Donald C. Henley, Antonin Bukovsky, Prem Seth & Jay Wimalasena. (2001) Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function. Molecular and Cellular Biology 21:3, pages 794-810.
Read now
Read now
Vjekoslav Dulić, Georges-Edouard Beney, Guillaume Frebourg, Linda F. Drullinger & Gretchen H. Stein. (2000) Uncoupling between Phenotypic Senescence and Cell Cycle Arrest in Aging p21-Deficient Fibroblasts. Molecular and Cellular Biology 20:18, pages 6741-6754.
Read now
Read now
T. Rabe, M. K. Bohlmann, S. Rehberger-Schneider & S. Prifti. (2000) Induction of estrogen receptor-α and -β activities by synthetic progestins. Gynecological Endocrinology 14:2, pages 118-126.
Read now
Read now
Wei Tong & Jeffrey W. Pollard. (1999) Progesterone Inhibits Estrogen-Induced Cyclin D1 and cdk4 Nuclear Translocation, Cyclin E- and Cyclin A-cdk2 Kinase Activation, and Cell Proliferation in Uterine Epithelial Cells in Mice. Molecular and Cellular Biology 19:3, pages 2251-2264.
Read now
Read now
Gretchen H. Stein, Linda F. Drullinger, Alexandre Soulard & Vjekoslav Dulić. (1999) Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts. Molecular and Cellular Biology 19:3, pages 2109-2117.
Read now
Read now
Hong Jiang, Hubert S. Chou & Liang Zhu. (1998) Requirement of Cyclin E-Cdk2 Inhibition in p16-Mediated Growth Suppression. Molecular and Cellular Biology 18:9, pages 5284-5290.
Read now
Read now
Owen W. J. Prall, Eileen M. Rogan, Elizabeth A. Musgrove, Colin K. W. Watts & Robert L. Sutherland. (1998) c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry. Molecular and Cellular Biology 18:8, pages 4499-4508.
Read now
Read now
Articles from other publishers (171)
Frank Z. Stanczyk, Rachel S. Mandelbaum, Harpreet Matharu, Christina E. Dancz & Mark E. Sherman. (2023) Endometrial safety of low-dose vaginal estrogens. Menopause 30:6, pages 650-658.
Crossref
Crossref
Susanne Schüler-Toprak, Maciej Skrzypczak, Carsten Gründker, Olaf Ortmann & Oliver Treeck. (2023) Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer. Cancers 15:10, pages 2845.
Crossref
Crossref
Nesa Rashidi, Soheila Arefi, Maryam Sadri & Ali-Akbar Delbandi. (2023) Effect of active vitamin D on proliferation, cell cycle and apoptosis in endometriotic stromal cells. Reproductive BioMedicine Online 46:3, pages 436-445.
Crossref
Crossref
Giselle A. Abruzzese, Aimé F. Silva, Mariela E. Velazquez, Maria‐José Ferrer & Alicia B. Motta. (2022) Hyperandrogenism and Polycystic ovary syndrome: Effects in pregnancy and offspring development. WIREs Mechanisms of Disease 14:5.
Crossref
Crossref
Jorge Gómez Tejeda Zañudo, Pingping Mao, Clara Alcon, Kailey Kowalski, Gabriela N. Johnson, Guotai Xu, Jose Baselga, Maurizio Scaltriti, Anthony Letai, Joan Montero, Réka Albert & Nikhil Wagle. (2021) Cell Line–Specific Network Models of ER+ Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations. Cancer Research 81:17, pages 4603-4617.
Crossref
Crossref
Eriko Ohsaki & Keiji Ueda. (2020) Interplay Between KSHV and the Host DNA Damage Response. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Laura Verardi, Jessica Fiori, Vincenza Andrisano, Alessandra Locatelli, Rita Morigi, Marina Naldi, Carlo Bertucci, Elena Strocchi, Carla Boga, Gabriele Micheletti & Natalia Calonghi. (2020) Indole Derivative Interacts with Estrogen Receptor Beta and Inhibits Human Ovarian Cancer Cell Growth. Molecules 25:19, pages 4438.
Crossref
Crossref
Taha Koray Sahin, Oktay Halit Aktepe, Fatih Mehmet Uckun & Suayib Yalcin. (2020) Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61. Anti-Cancer Drugs 31:6, pages 609-616.
Crossref
Crossref
Sebastiano Andò, Giuseppina Daniela Naimo, Luca Gelsomino, Stefania Catalano & Loredana Mauro. (2020) Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression. Obesity Reviews 21:5.
Crossref
Crossref
Yawei Shi, Yang Zhao, Yunjian Zhang, NiJiati AiErken, Nan Shao, Runyi Ye, Ying Lin & Shenming Wang. (2018) AFF3 upregulation mediates tamoxifen resistance in breast cancers. Journal of Experimental & Clinical Cancer Research 37:1.
Crossref
Crossref
Sachi Horibata, Edward J. Rice, Hui Zheng, Chinatsu Mukai, Tinyi Chu, Brooke A. Marks, Scott A. Coonrod & Charles G. Danko. (2018) A bi-stable feedback loop between GDNF, EGR1, and ERα contribute to endocrine resistant breast cancer. PLOS ONE 13:4, pages e0194522.
Crossref
Crossref
Susanne Schüler-Toprak, Christoph Moehle, Maciej Skrzypczak, Olaf Ortmann & Oliver Treeck. (2017) Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells. BMC Cancer 17:1.
Crossref
Crossref
Yi Tang, Jun Wang, Jinghua Cheng & Lijun Wang. (2017) Antiestrogenic Activity of Triptolide in Human Breast Cancer Cells MCF-7 and Immature Female Mouse. Drug Development Research 78:3-4, pages 164-169.
Crossref
Crossref
Rosa-Maria Ferraiuolo, Janice Tubman, Indrajit Sinha, Caroline Hamm & Lisa Ann Porter. (2017) The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance. Oncotarget 8:14, pages 23337-23352.
Crossref
Crossref
J A Menendez & R Lupu. (2017) Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells. Oncogenesis 6:2, pages e299-e299.
Crossref
Crossref
A. Crockford, L.P. Zalmas, E. Grönroos, S.M. Dewhurst, N. McGranahan, M.E. Cuomo, V. Encheva, A.P. Snijders, J. Begum, S. Purewal, J. Cerveira, H. Patel, M.J. Renshaw & C. Swanton. (2017) Cyclin D mediates tolerance of genome-doubling in cancers with functional p53. Annals of Oncology 28:1, pages 149-156.
Crossref
Crossref
Sarah M. Bernhardt, Pallave Dasari, David Walsh, Amanda R. Townsend, Timothy J. Price & Wendy V. Ingman. (2016) Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women. Frontiers in Oncology 6.
Crossref
Crossref
Marie Maynadier, Ilaria Basile, Audrey Gallud, Magali Gary-Bobo & Marcel Garcia. (2016) Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer. Oncology Reports 36:2, pages 1127-1134.
Crossref
Crossref
Sharon Pok, Vanessa A Barn, Heng Jian Wong, Anneke C Blackburn, Philip Board, Geoffrey C Farrell & Narci C Teoh. (2016) Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis. Journal of Gastroenterology and Hepatology 31:6, pages 1210-1219.
Crossref
Crossref
Rita de Cássia Pereira da Costa e Silva, Kátia Karina Verolli de Oliveira Moura, Circoncisto Laurentino Ribeiro Júnior & Lidia Andreu Guillo. (2016) Estrogen signaling in the proliferative endometrium: implications in endometriosis. Revista da Associação Médica Brasileira 62:1, pages 72-77.
Crossref
Crossref
S. Sathya, S. Sudhagar & B.S. Lakshmi. (2015) Estrogen suppresses breast cancer proliferation through GPER / p38 MAPK axis during hypoxia. Molecular and Cellular Endocrinology 417, pages 200-210.
Crossref
Crossref
Esther A. Peterson, Edmund C. Jenkins, Kristopher A. Lofgren, Natasha Chandiramani, Hui Liu, Evelyn Aranda, Maryia Barnett & Paraic A. Kenny. (2015) Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERα-Positive Breast Cancer. Cancer Research 75:22, pages 4830-4838.
Crossref
Crossref
Maiko Okada, Fumiaki Ohtake, Hiroyuki Nishikawa, Wenwen Wu, Yasushi Saeki, Keiji Takana & Tomohiko Ohta. (2015) Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation. Molecular Endocrinology 29:11, pages 1646-1657.
Crossref
Crossref
Loredana Mauro, Michele Pellegrino, Francesca Giordano, Emilia Ricchio, Pietro Rizza, Francesca De Amicis, Stefania Catalano, Daniela Bonofiglio, Maria Luisa Panno & Sebastiano Andò. (2015) Estrogen receptor‐α drives adiponectin effects on cyclin D1 expression in breast cancer cells. The FASEB Journal 29:5, pages 2150-2160.
Crossref
Crossref
Chao Wang, Xiaoling Du, Rui Yang, Jie Liu, Da Xu, Jiandang Shi, Linfeng Chen, Rui Shao, Guanwei Fan, Xiumei Gao, Guo Tian, Yan Zhu & Ju Zhang. (2015) The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats. The Journal of Steroid Biochemistry and Molecular Biology 145, pages 28-37.
Crossref
Crossref
Morassa Mohseni, Justin Cidado, Sarah Croessmann, Karen Cravero, Ashley Cimino-Mathews, Hong Yuen Wong, Rob Scharpf, Daniel J. Zabransky, Abde M. Abukhdeir, Joseph P. Garay, Grace M. Wang, Julia A. Beaver, Rory L. Cochran, Brian G. Blair, D. Marc Rosen, Bracha Erlanger, Pedram Argani, Paula J. Hurley, Josh Lauring & Ben Ho Park. (2014)
MACROD2
overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers
. Proceedings of the National Academy of Sciences 111:49, pages 17606-17611.
Crossref
Crossref
Liping Chen, Geng Chen, Yibin Guo, Lei Liu, Li Xiao, Wenmei Fan, Bingyi Shi & Yeyong Qian. (2014) Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats. Liver Transplantation 20:11, pages 1317-1326.
Crossref
Crossref
J. M. Dixon. (2014) Endocrine Resistance in Breast Cancer. New Journal of Science 2014, pages 1-27.
Crossref
Crossref
Anna Maria Wróbel & Ewa Łucja Gregoraszczuk. (2014) Differential effect of methyl-, butyl- and propylparaben and 17β-estradiol on selected cell cycle and apoptosis gene and protein expression in MCF-7 breast cancer cells and MCF-10A non-malignant cells. Journal of Applied Toxicology 34:9, pages 1041-1050.
Crossref
Crossref
RUBÍ VIEDMA-RODRÍGUEZ, LUIS BAIZA-GUTMAN, FABIO SALAMANCA-GÓMEZ, MARIANA DIAZ-ZARAGOZA, GUADALUPE MARTÍNEZ-HERNÁNDEZ, RUTH RUIZ ESPARZA-GARRIDO, MIGUEL ANGEL VELÁZQUEZ-FLORES & DIEGO ARENAS-ARANDA. (2014) Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (Review). Oncology Reports 32:1, pages 3-15.
Crossref
Crossref
Zhuan Zhou, Joe X. Qiao, Amit Shetty, George Wu, Yi Huang, Nancy E. Davidson & Yong Wan. (2013) RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cellular and Molecular Life Sciences 71:8, pages 1549-1549.
Crossref
Crossref
Emilio Lecona, Luis Alejandro Rojas, Roberto Bonasio, Andrew Johnston, Oscar Fernández-Capetillo & Danny Reinberg. (2013) Polycomb Protein SCML2 Regulates the Cell Cycle by Binding and Modulating CDK/CYCLIN/p21 Complexes. PLoS Biology 11:12, pages e1001737.
Crossref
Crossref
Sharon Pok, Victoria Wen, Nicholas Shackel, Amber Alsop, Pawan Pyakurel, Aude Fahrer, Geoffrey C Farrell & Narci C Teoh. (2013)
Cyclin E facilitates dysplastic hepatocytes to bypass G
1
/S checkpoint in hepatocarcinogenesis
. Journal of Gastroenterology and Hepatology 28:9, pages 1545-1554.
Crossref
Crossref
Fiona Simpkins, Arlene Garcia-Soto & Joyce Slingerland. (2013) New insights on the role of hormonal therapy in ovarian cancer. Steroids 78:6, pages 530-537.
Crossref
Crossref
Carina Fung, Gulietta M. Pupo, Richard A. Scolyer, Richard F. Kefford & Helen Rizos. (2013)
p16
INK
4a
deficiency promotes DNA hyper-replication and genetic instability in melanocytes
. Pigment Cell & Melanoma Research 26:2, pages 236-246.
Crossref
Crossref
Bramanandam ManavathiOindrilla DeyVijay Narsihma Reddy GajulapalliRaghavendra Singh BhatiaSuresh BugideRakesh Kumar. (2013) Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple. Endocrine Reviews 34:1, pages 1-32.
Crossref
Crossref
Marion Lapierre, Aurélie Docquier, Audrey Castet-Nicolas, Stéphan Jalaguier, Catherine Teyssier, Patrick Augereau & Vincent Cavaillès. (2013) Dialogue between estrogen receptor and E2F signaling pathways: The transcriptional coregulator RIP140 at the crossroads. Advances in Bioscience and Biotechnology 04:10, pages 45-54.
Crossref
Crossref
Julia Häring, Susanne Schüler, Claus Lattrich, Olaf Ortmann & Oliver Treeck. (2012) Role of estrogen receptor β in gynecological cancer. Gynecologic Oncology 127:3, pages 673-676.
Crossref
Crossref
Karin Beelen, Wilbert Zwart & Sabine C. Linn. (2012) Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?. Nature Reviews Clinical Oncology 9:9, pages 529-541.
Crossref
Crossref
M. P. H. M. Jansen, E. A. Reijm, A. M. Sieuwerts, K. Ruigrok-Ritstier, M. P. Look, F. G. Rodríguez-González, A. A. J. Heine, J. W. Martens, S. Sleijfer, J. A. Foekens & E. M. J. J. Berns. (2011) High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer. Breast Cancer Research and Treatment 133:3, pages 937-947.
Crossref
Crossref
Chantal Beatrice Magne Nde, Dieudonne Njamen, Stephen Tanee Fomum, Jean Wandji, Evan Simpson, Colin Clyne & Günter Vollmer. (2012) In vitro estrogenic activity of two major compounds from the stem bark of Erythrina lysistemon (Fabaceae). European Journal of Pharmacology 674:2-3, pages 87-94.
Crossref
Crossref
Robert D. Koos. (2011) Minireview: Putting Physiology Back into Estrogens' Mechanism of Action. Endocrinology 152:12, pages 4481-4488.
Crossref
Crossref
Yi Chen, Edwin A. Alvarez, Diana Azzam, Seth A. Wander, Natalia Guggisberg, Mercè Jordà, Zhenlin Ju, Bryan T. Hennessy & Joyce M. Slingerland. (2010) Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo. Breast Cancer Research and Treatment 128:1, pages 69-78.
Crossref
Crossref
Joseph Levy, Shlomo Walfisch, Andrea Atzmon, Keren Hirsch, Marina Khanin, Karin Linnewiel, Yael Morag, Hagar Salman, Anna Veprik, Michael Danilenko & Yoav Sharoni. 2011. Vegetables, Whole Grains, and Their Derivatives in Cancer Prevention. Vegetables, Whole Grains, and Their Derivatives in Cancer Prevention
47
66
.
M D Lacher, R Pincheira, Z Zhu, B Camoretti-Mercado, M Matli, R S Warren & A F Castro. (2010) Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis. Oncogene 29:50, pages 6543-6556.
Crossref
Crossref
Takako Sakamoto, Hyogo Horiguchi, Etsuko Oguma & Fujio Kayama. (2010) Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells. The Journal of Nutritional Biochemistry 21:9, pages 856-864.
Crossref
Crossref
J L Dean, C Thangavel, A K McClendon, C A Reed & E S Knudsen. (2010) Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure. Oncogene 29:28, pages 4018-4032.
Crossref
Crossref
Xiaofei Chang, Constance L. Monitto, Semra Demokan, Myoung Sook Kim, Steven S. Chang, Xiaoli Zhong, Joseph A. Califano & David Sidransky. (2010) Identification of Hypermethylated Genes Associated with Cisplatin Resistance in Human Cancers. Cancer Research 70:7, pages 2870-2879.
Crossref
Crossref
Li-Ping Chen, Qi-Hao Zhang, Geng Chen, Ye-Yong Qian, Bing-Yi Shi & Jia-Hong Dong. (2010) Rapamycin inhibits cholangiocyte regeneration by blocking interleukin-6-induced activation of signal transducer and activator of transcription 3 after liver transplantation. Liver Transplantation 16:2, pages 204-214.
Crossref
Crossref
N Johnson, J Bentley, L-Z Wang, D R Newell, C N Robson, G I Shapiro & N J Curtin. (2009) Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. British Journal of Cancer 102:2, pages 342-350.
Crossref
Crossref
Yi Chen, Natalia Guggisberg, Merce Jorda, Ana Gonzalez-Angulo, Bryan Hennessy, Gordon B. Mills, Chen-Keat Tan & Joyce M. Slingerland. (2009)
Combined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth
In vivo
and Bypass Pathways Are Activated in AZD0530-Resistant Tumors
. Clinical Cancer Research 15:10, pages 3396-3405.
Crossref
Crossref
Sudipan Karmakar, Estrella A. Foster & Carolyn L. Smith. (2009) Unique Roles of p160 Coactivators for Regulation of Breast Cancer Cell Proliferation and Estrogen Receptor-α Transcriptional Activity. Endocrinology 150:4, pages 1588-1596.
Crossref
Crossref
Signe Borgquist, Karin Jirström, Lola Anagnostaki, Jonas Manjer & Göran Landberg. (2009) Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer. International Journal of Cancer 124:2, pages 402-411.
Crossref
Crossref
Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove & Robert L. Sutherland. 2009. Hormone Therapy in Breast and Prostate Cancer. Hormone Therapy in Breast and Prostate Cancer
17
45
.
Karishma M. Fernandes, Corinth A. Auld, Robin G. Hopkins & Ron F. Morrison. (2008) Helenalin-mediated post-transcriptional regulation of p21(Cip1) inhibits 3T3-L1 preadipocyte proliferation. Journal of Cellular Biochemistry 105:3, pages 913-921.
Crossref
Crossref
Abde M. Abukhdeir & Ben Ho Park. (2008) p21 and p27: roles in carcinogenesis and drug resistance. Expert Reviews in Molecular Medicine 10.
Crossref
Crossref
A Chatterjee, X Chang, J K Nagpal, S Chang, S Upadhyay, J Califano, B Trink & D Sidransky. (2008) Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis. Oncogene 27:26, pages 3710-3720.
Crossref
Crossref
Wei Tong, Andrea Niklaus, Liyin Zhu, Haiyan Pan, Bo Chen, Mira Aubuchon, Nanette Santoro & Jeffrey W Pollard. 2008. Endometrium, The. Endometrium, The
99
122
.
Marie Maynadier, Jean‐Marie Ramirez, Anne‐Marie Cathiard, Nadine Platet, Delphine Gras, Michel Gleizes, M. Saeed Sheikh, Philippe Nirde & Marcel Garcia. (2007)
Unliganded estrogen receptor α inhibits breast cancer cell growth through interaction with a cyclin‐dependent kinase inhibitor (p21
WAF1
)
. The FASEB Journal 22:3, pages 671-681.
Crossref
Crossref
Joseph Levy, Shlomo Walfisch, Yossi Walfisch, Amit Nahum, Keren Hirsch, Michael Danilenko & Yoav Sharoni. 2008. Tomatoes and Tomato Products. Tomatoes and Tomato Products
395
410
.
Abde M. AbukhdeirMichele I. Vitolo, Pedram ArganiAngelo M. De MarzoBedri KarakasHiroyuki KonishiJohn P. GustinJosh LauringJoseph P. GarayCourtney PendletonYuko KonishiBrian G. BlairKeith BrennerElizabeth Garrett-Mayer, Hetty CarrawayKurtis E. Bachman & Ben Ho Park. (2008) Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proceedings of the National Academy of Sciences 105:1, pages 288-293.
Crossref
Crossref
Robert L. Sutherland, C. Marcelo Sergio, CatrionaM. McNeil, Luke R. Anderson, Claire K. Inman, Alison J. Butt & Elizabeth A. Musgrove. 2008. Hormonal Control of Cell Cycle. Hormonal Control of Cell Cycle
123
138
.
Alison J. Butt, C. Elizabeth Caldon, Catriona M. McNeil, Alexander Swarbrick, Elizabeth A. Musgrove & Robert L. Sutherland. 2008. Innovative Endocrinology of Cancer. Innovative Endocrinology of Cancer
189
205
.
Walter D. Sierralta, María J. Epuñan, José M. Reyes, Luis E. Valladares & Ana M. Pino. 2008. Hormonal Carcinogenesis V. Hormonal Carcinogenesis V
463
468
.
Hemant Varma, Andrew J. Skildum & Susan E. Conrad. (2007) Functional Ablation of pRb Activates Cdk2 and Causes Antiestrogen Resistance in Human Breast Cancer Cells. PLoS ONE 2:12, pages e1256.
Crossref
Crossref
Wei-dong Han, Ya-li Zhao, Zhi-qing Wu, Yuan-guang Meng, Li Zang & Yi-ming Mu. (2007) Estrogen receptor α(ERα) target gene LRP16 interacts with ERα and enhances receptor’s transcriptional activity. Chinese Journal of Cancer Research 19:4, pages 233-237.
Crossref
Crossref
Jun Watanabe, Yuko Kamata, Norihisa Seo, Isao Okayasu & Hiroyuki Kuramoto. (2007) Stimulatory effect of estrogen on the growth of endometrial cancer cells is regulated by cell-cycle regulators. The Journal of Steroid Biochemistry and Molecular Biology 107:3-5, pages 163-171.
Crossref
Crossref
Maricarmen D. Planas-Silva & Kecia N. Hamilton. (2006) Targeting c-Src kinase enhances tamoxifen’s inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins. Cancer Chemotherapy and Pharmacology 60:4, pages 535-543.
Crossref
Crossref
Maricarmen D. Planas-Silva & Irina S. Filatova. (2007) Estrogen-dependent regulation of Eg5 in breast cancer cells. Anti-Cancer Drugs 18:7, pages 773-779.
Crossref
Crossref
Robert-Alain Toillon, Nicolas Magné, Ioanna Laïos, Pierre Castadot, Eric Kinnaert, Paul Van Houtte, Christine Desmedt, Guy Leclercq & Marc Lacroix. (2007) Estrogens decrease γ-ray–induced senescence and maintain cell cycle progression in breast cancer cells independently of p53. International Journal of Radiation Oncology*Biology*Physics 67:4, pages 1187-1200.
Crossref
Crossref
Sandra Cascio, Viviana Bartella, Cecilia Garofalo, Antonio Russo, Antonio Giordano & Eva Surmacz. (2007) Insulin-like Growth Factor 1 Differentially Regulates Estrogen Receptor-dependent Transcription at Estrogen Response Element and AP-1 Sites in Breast Cancer Cells. Journal of Biological Chemistry 282:6, pages 3498-3506.
Crossref
Crossref
Galia Karp, Adva Maissel & Etta Livneh. (2007) Hormonal regulation of PKC: Estrogen up-regulates PKCη expression in estrogen-responsive breast cancer cells. Cancer Letters 246:1-2, pages 173-181.
Crossref
Crossref
Rajendra Bhati, Yesim Gökmen-Polar, George W. SledgeJr.Jr., Cheng Fan, Harikrishna Nakshatri, David Ketelsen, Christoph H. Borchers, Michael J. Dial, Cam Patterson & Nancy Klauber-DeMore. (2007) 2-Methoxyestradiol Inhibits the Anaphase-Promoting Complex and Protein Translation in Human Breast Cancer Cells. Cancer Research 67:2, pages 702-708.
Crossref
Crossref
Laura Lambert & Khandan Keyomarsi. 2007. Breast Cancer Chemosensitivity. Breast Cancer Chemosensitivity
52
69
.
Robin L. Kilker & Maricarmen D. Planas-Silva. (2006) Cyclin D1 Is Necessary for Tamoxifen-Induced Cell Cycle Progression in Human Breast Cancer Cells. Cancer Research 66:23, pages 11478-11484.
Crossref
Crossref
Petra den Hollander, Suresh K. Rayala, Dawn Coverley & Rakesh Kumar. (2006) Ciz1, a Novel DNA-Binding Coactivator of the Estrogen Receptor α, Confers Hypersensitivity to Estrogen Action. Cancer Research 66:22, pages 11021-11029.
Crossref
Crossref
Ruth Lupu & Javier A. Menendez. (2006) Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?. Endocrinology 147:9, pages 4056-4066.
Crossref
Crossref
Amit Nahum, Lior Zeller, Michael Danilenko, Owen W. J. Prall, Colin K. W. Watts, Robert L. Sutherland, Joseph Levy & Yoav Sharoni. (2006) Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. European Journal of Nutrition 45:5, pages 275-282.
Crossref
Crossref
Petra den Hollander & Rakesh Kumar. (2006) Dynein Light Chain 1 Contributes to Cell Cycle Progression by Increasing Cyclin-Dependent Kinase 2 Activity in Estrogen-Stimulated Cells. Cancer Research 66:11, pages 5941-5949.
Crossref
Crossref
Maricarmen D. Planas-Silva, Richard D. Bruggeman, Ronald T. Grenko & J. Stanley Smith. (2006) Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer. Biochemical and Biophysical Research Communications 341:1, pages 73-81.
Crossref
Crossref
Jean-Sébastien Annicotte, Carine Chavey, Nadège Servant, Jacques Teyssier, Aurélie Bardin, Anne Licznar, Eric Badia, Pascal Pujol, Françoise Vignon, Thierry Maudelonde, Gwendal Lazennec, Vincent Cavailles & Lluis Fajas. (2005) The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene 24:55, pages 8167-8175.
Crossref
Crossref
Jennica L. Zaro & Wei-Chiang Shen. (2005) Cytosolic delivery of a p16-peptide oligoarginine conjugate for inhibiting proliferation of MCF7 cells. Journal of Controlled Release 108:2-3, pages 409-417.
Crossref
Crossref
Kelly K. Hunt & Khandan Keyomarsi. (2005) Cyclin E as a prognostic and predictive marker in breast cancer. Seminars in Cancer Biology 15:4, pages 319-326.
Crossref
Crossref
Andrew Arnold & Alexandros Papanikolaou. (2005) Cyclin D1 in Breast Cancer Pathogenesis. Journal of Clinical Oncology 23:18, pages 4215-4224.
Crossref
Crossref
Shibani Mukherjee & Susan E. Conrad. (2005) c-Myc Suppresses p21WAF1/CIP1 Expression during Estrogen Signaling and Antiestrogen Resistance in Human Breast Cancer Cells. Journal of Biological Chemistry 280:18, pages 17617-17625.
Crossref
Crossref
Linda Björnström & Maria Sjöberg. (2005) Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes. Molecular Endocrinology 19:4, pages 833-842.
Crossref
Crossref
Joanne Kotsopoulos & Steven A. Narod. (2005) Brief Report: Towards a dietary prevention of hereditary breast cancer. Cancer Causes & Control 16:2, pages 125-138.
Crossref
Crossref
Stephen Safe. 2004. Endocrine Disruptors. Endocrine Disruptors
249
287
.
Robin L. Kilker, Michael W. Hartl, Tina M. Rutherford & Maricarmen D. Planas-Silva. (2004) Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 92:1-2, pages 63-71.
Crossref
Crossref
Virgil T. Gaddy, John T. Barrett, Jennifer N. Delk, Andre M. Kallab, Alan G. Porter & Patricia V. Schoenlein. (2004) Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells. Clinical Cancer Research 10:15, pages 5215-5225.
Crossref
Crossref
Denise Scholtens, Alexander Miron, Faisal M. Merchant, Arden Miller, Penelope L. Miron, J. Dirk Iglehart & Robert Gentleman. (2004) Analyzing factorial designed microarray experiments. Journal of Multivariate Analysis 90:1, pages 19-43.
Crossref
Crossref
Javier A Menendez, Bharvi P Oza, Ella Atlas, Vishal A Verma, Inderjit Mehmi & Ruth Lupu. (2004) Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells. Oncogene 23:28, pages 4945-4958.
Crossref
Crossref
Said Akli, Ping-Ju Zheng, Asha S. Multani, Hannah F. Wingate, Sen Pathak, Ning Zhang, Susan L. Tucker, Sandy Chang & Khandan Keyomarsi. (2004) Tumor-Specific Low Molecular Weight Forms of Cyclin E Induce Genomic Instability and Resistance to p21, p27, and Antiestrogens in Breast Cancer. Cancer Research 64:9, pages 3198-3208.
Crossref
Crossref
M. P. Waalkes, J. Liu, H. Chen, Y. Xie, W. E. Achanzar, Y.-S. Zhou, M.-L. Cheng & B. A. Diwan. (2004) Estrogen Signaling in Livers of Male Mice With Hepatocellular Carcinoma Induced by Exposure to Arsenic In Utero. JNCI Journal of the National Cancer Institute 96:6, pages 466-474.
Crossref
Crossref
Tomas Barkhem, Stefan Nilsson & Jan-??ke Gustafsson. (2004) Molecular Mechanisms, Physiological Consequences and Pharmacological Implications of Estrogen Receptor Action. American Journal of PharmacoGenomics 4:1, pages 19-28.
Crossref
Crossref
James S. Foster, Romaine I. Fernando, Noriko Ishida, Keiichi I. Nakayama & Jay Wimalasena. (2003) Estrogens Down-regulate p27 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway. Journal of Biological Chemistry 278:42, pages 41355-41366.
Crossref
Crossref
Sophie F. Doisneau-Sixou, Philippe Cestac, Jean-Charles Faye, Gilles Favre & Robert L. Sutherland. (2003) Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI-277 on inhibition of MCF-7 breast cancer cell-cycle progression. International Journal of Cancer 106:5, pages 789-798.
Crossref
Crossref
Pierre Rudolph, Heidi Kühling, Per Alm, Mårten Fernö, Bo Baldetorp, Håkan Olsson & Reza Parwaresch. (2003) Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer. International Journal of Cancer 105:5, pages 674-680.
Crossref
Crossref
Heidi Kühling, Per Alm, Håkan Olsson, Mårten Fernö, Bo Baldetorp, Reza Parwaresch & Pierre Rudolph. (2003) Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer. The Journal of Pathology 199:4, pages 424-431.
Crossref
Crossref
Jun Watanabe, Yuko Kamata, Tadayuki Kanai, Norihisa Seo, Takeshi Fujisawa, Yukari Nishimura, Mieko Hamano, Toshiko Jobo & Hiroyuki Kuramoto. 2003. Cell and Molecular Biology of Endometrial Carcinoma. Cell and Molecular Biology of Endometrial Carcinoma
93
106
.
Eric MJ Bindels, François Lallemand, Astrid Balkenende, Desiree Verwoerd & Rob Michalides. (2002) Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Oncogene 21:53, pages 8158-8165.
Crossref
Crossref
Masayo Fujita, Tomohiko Urano, Kuniko Horie, Kazuhiro Ikeda, Tohru Tsukui, Hideoki Fukuoka, Osamu Tsutsumi, Yasuyoshi Ouchi & Satoshi Inoue. (2002) Estrogen activates cyclin-dependent kinases 4 and 6 through induction of cyclin D in rat primary osteoblasts. Biochemical and Biophysical Research Communications 299:2, pages 222-228.
Crossref
Crossref
Yueh-Chiang Hu, Chih-Rong Shyr, Wenyi Che, Xiao-Min Mu, Eungseok Kim & Chawnshang Chang. (2002) Suppression of Estrogen Receptor-mediated Transcription and Cell Growth by Interaction with TR2 Orphan Receptor. Journal of Biological Chemistry 277:37, pages 33571-33579.
Crossref
Crossref
Kevin Shoulars, Trellis Brown, Mary Ann Alejandro, Jan Crowley & Barry M Markaverich. (2002) Identification of nuclear type II [3H]estradiol binding sites as histone H4. Biochemical and Biophysical Research Communications 296:5, pages 1083-1090.
Crossref
Crossref
Meng-Min Liu, Chris Albanese, Carol M. Anderson, Kristin Hilty, Paul Webb, Rosalie M. Uht, Richard H. PriceJr.Jr., Richard G. Pestell & Peter J. Kushner. (2002) Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression. Journal of Biological Chemistry 277:27, pages 24353-24360.
Crossref
Crossref
Rob J. A. M. Michalides, Michiel van de Brekel & Fons Balm. (2002) Defects in G1-S cell cycle control in head and neck cancer: A review. Head & Neck 24:7, pages 694-704.
Crossref
Crossref
Edward K. Lobenhofer, Lee Bennett, P. LouAnn Cable, Leping Li, Pierre R. Bushel & Cynthia A. Afshari. (2002) Regulation of DNA Replication Fork Genes by 17β-Estradiol. Molecular Endocrinology 16:6, pages 1215-1229.
Crossref
Crossref
Asgerally Fazleabas & J Kim. 2002. The Endometrium. The Endometrium
123
134
.
Jeannine Botos, Roger SmithIIIIII & Deborah T. Kochevar. (2016) Retinoblastoma Function is a Better Indicator of Cellular Phenotype in Cultured Breast Adenocarcinoma Cells than Retinoblastoma Expression. Experimental Biology and Medicine 227:5, pages 354-362.
Crossref
Crossref
Shamila Ahamed, James S. Foster, Antonin Bukovsky, J. Alan Diehl & Jay Wimalasena. (2002) Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells. Molecular Carcinogenesis 34:1, pages 45-58.
Crossref
Crossref
Andrew J. Skildum, Shibani Mukherjee & Susan E. Conrad. (2002) The Cyclin-dependent Kinase Inhibitor p21WAF1/Cip1 Is an Antiestrogen-regulated Inhibitor of Cdk4 in Human Breast Cancer Cells. Journal of Biological Chemistry 277:7, pages 5145-5152.
Crossref
Crossref
R Michalides, H van Tinteren, A Balkenende, J B Vermorken, J Benraadt, J Huldij & P van Diest. (2002) Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment. British Journal of Cancer 86:3, pages 402-408.
Crossref
Crossref
JEANNINE BOTOS, ROLA BARHOUMI, ROBERT BURGHARDT & DEBORAH T. KOCHEVAR. (2002) Rb LOCALIZATION AND PHOSPHORYLATION KINETICS CORRELATE WITH THE CELLULAR PHENOTYPE OF CULTURED BREAST ADENOCARCINOMA CELLS. In Vitro Cellular & Developmental Biology - Animal 38:4, pages 235.
Crossref
Crossref
Göran Landberg. 2002.
35
56
.
Douglas Yee & Carol A. Lange. 2002. Selective Estrogen Receptor Modulators. Selective Estrogen Receptor Modulators
77
95
.
G. Prem Veer Reddy, Eugenia Cifuentes, Mani Menon & Evelyn R. Barrack. 2002. Steroid Hormones and Cell Cycle Regulation. Steroid Hormones and Cell Cycle Regulation
111
135
.
Jason S. Carroll, Owen W. J. Prall, Claudio M. Sergio, Eileen M. Rogan, Colin K. W. Watts, Elizabeth A. Musgrove & Robert L. Sutherland. 2002. Steroid Hormones and Cell Cycle Regulation. Steroid Hormones and Cell Cycle Regulation
57
71
.
Scott Wadler. (2001) Perspectives for cancer therapies with cdk2 inhibitors. Drug Resistance Updates 4:6, pages 347-367.
Crossref
Crossref
Jeffrey C.H. Donovan, Andrea Milic & Joyce M. Slingerland. (2001) Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells. Journal of Biological Chemistry 276:44, pages 40888-40895.
Crossref
Crossref
Owen W.J. Prall, Jason S. Carroll & Robert L. Sutherland. (2001) A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E·Cdk2. Journal of Biological Chemistry 276:48, pages 45433-45442.
Crossref
Crossref
Eyal Fima, Marat Shtutman, Pazit Libros, Adva Missel, Galit Shahaf, Galia Kahana & Etta Livneh. (2001) PKCη enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells. Oncogene 20:46, pages 6794-6804.
Crossref
Crossref
James S. Foster, Donald C. Henley, Shamila Ahamed & Jay Wimalasena. (2001) Estrogens and cell-cycle regulation in breast cancer. Trends in Endocrinology & Metabolism 12:7, pages 320-327.
Crossref
Crossref
Tae Jung Jang, Jae Hum Park, Mee Yon Cho & Jung Ran Kim. (2001) Chemically induced rat mammary tumor treated with tamoxifen showed decreased expression of cyclin D1, cyclin E, and p21Cip1. Cancer Letters 170:2, pages 109-116.
Crossref
Crossref
Emely Castro-Rivera, Ismael Samudio & Stephen Safe. (2001) Estrogen Regulation of Cyclin D1 Gene Expression in ZR-75 Breast Cancer Cells Involves Multiple Enhancer Elements. Journal of Biological Chemistry 276:33, pages 30853-30861.
Crossref
Crossref
M. Marino, E. Distefano, A. Trentalance & C.L. Smith. (2001) Estradiol-induced IP3 mediates the estrogen receptor activity expressed in human cells. Molecular and Cellular Endocrinology 182:1, pages 19-26.
Crossref
Crossref
Gudrun Urban, Teresa Golden, Ileana V. Aragon, Jonathan G. Scammell, Nicholas M. Dean & Richard E. Honkanen. (2001) Identification of an Estrogen-inducible Phosphatase (PP5) That Converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-independent Phenotype when Expressed Constitutively. Journal of Biological Chemistry 276:29, pages 27638-27646.
Crossref
Crossref
Angela Lai, Boris Sarcevic, Owen W.J. Prall & Robert L. Sutherland. (2001) Insulin/Insulin-like Growth Factor-I and Estrogen Cooperate to Stimulate Cyclin E-Cdk2 Activation and Cell Cycle Progression in MCF-7 Breast Cancer Cells through Differential Regulation of Cyclin E and p21WAF1/Cip1. Journal of Biological Chemistry 276:28, pages 25823-25833.
Crossref
Crossref
Amit Nahum, Keren Hirsch, Michael Danilenko, Colin KW Watts, Owen WJ Prall, Joseph Levy & Yoav Sharoni. (2001) Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27Kip1 in the cyclin E–cdk2 complexes. Oncogene 20:26, pages 3428-3436.
Crossref
Crossref
Domenico Germano, Carmen Pacilio, Massimo Cancemi, Luigi Cicatiello, Lucia Altucci, Valeria Belsito Petrizzi, Carmine Sperandio, Salvatore Salzano, Rob J.A.M. Michalides, Yoichi Taya, Francesco Bresciani & Alessandro Weisz. (2001) Inhibition of Human Breast Cancer Cell Growth by Blockade of the Mevalonate-Protein Prenylation Pathway is not Prevented by Overexpression of Cyclin D1. Breast Cancer Research and Treatment 67:1, pages 23-33.
Crossref
Crossref
Paul Alban, Cliff Hurd, Sumi Dinda, Nidhi Khattree & V.K Moudgil. (2001) Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 77:2-3, pages 135-141.
Crossref
Crossref
Ismael Samudio, Carrie Vyhlidal, Fan Wang, Matthew Stoner, Ichen Chen, Michael Kladde, Rola Barhoumi, Robert Burghardt & Stephen Safe. (2001) Transcriptional Activation of Deoxyribonucleic Acid Polymerase α Gene Expression in MCF-7 Cells by 17β-Estradiol*. Endocrinology 142:3, pages 1000-1008.
Crossref
Crossref
Déborah Prévôt, Anne-Pierre Morel, Thibault Voeltzel, Marie-Claude Rostan, Ruth Rimokh, Jean-Pierre Magaud & Laura Corbo. (2001) Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional Complex. Journal of Biological Chemistry 276:13, pages 9640-9648.
Crossref
Crossref
V.K Moudgil, Sumi Dinda, Nidhi Khattree, Suresh Jhanwar, Paul Alban & Cliff Hurd. (2001) Hormonal regulation of tumor suppressor proteins in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 76:1-5, pages 105-117.
Crossref
Crossref
Ezhou Long, Anthoula Lazaris-Karatzas, Costas Karatzas & Xin Zhao. (2001) Overexpressing eukaryotic translation initiation factor 4E stimulates bovine mammary epithelial cell proliferation. The International Journal of Biochemistry & Cell Biology 33:2, pages 133-141.
Crossref
Crossref
Owen W. J. Prall, Eileen M. Rogan, Elizabeth A. Musgrove, Colin K. W. Watts & Robert L. Sutherland. 2001. Hormonal Carcinogenesis III. Hormonal Carcinogenesis III
220
227
.
Valeria Belsito Petrizzi, Luigi Cicatiello, Lucia Altucci, Raffaele Addeo, Raphaelle Borgo, Massimo Cancemi, Massimo Ancora, Juan Leyva, Francesco Bresciani & Alessandro Weisz. 2001. Hormonal Carcinogenesis III. Hormonal Carcinogenesis III
206
219
.
Daniel Harari & Yosef Yarden. (2000) Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 19:53, pages 6102-6114.
Crossref
Crossref
Jason S. Carroll, Owen W.J. Prall, Elizabeth A. Musgrove & Robert L. Sutherland. (2000) A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence. Journal of Biological Chemistry 275:49, pages 38221-38229.
Crossref
Crossref
Xuedong Liu, Yin Sun, Marcelo Ehrlich, Trent Lu, Yoel Kloog, Robert A Weinberg, Harvey F Lodish & Yoav I Henis. (2000) Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization. Oncogene 19:51, pages 5926-5935.
Crossref
Crossref
Joelle Dupont, Michael Karas & Derek LeRoith. (2000) The Potentiation of Estrogen on Insulin-like Growth Factor I Action in MCF-7 Human Breast Cancer Cells Includes Cell Cycle Components. Journal of Biological Chemistry 275:46, pages 35893-35901.
Crossref
Crossref
Hemant Varma & Susan E Conrad. (2000) Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain. Oncogene 19:41, pages 4746-4753.
Crossref
Crossref
Ayako Yamamoto, Yoshihiro Hashimoto, Kenjiro Kohri, Etsuro Ogata, Shige-aki Kato, Kyoji Ikeda & Makoto Nakanishi. (2000) Cyclin E as a Coactivator of the Androgen Receptor. The Journal of Cell Biology 150:4, pages 873-880.
Crossref
Crossref
Sandrine Cariou, Jeffrey C. H. Donovan, W. M. Flanagan, Andrea Milic, Nandita Bhattacharya & Joyce M. Slingerland. (2000)
Down-regulation of p21
WAF1/CIP1
or p27
Kip1
abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells
. Proceedings of the National Academy of Sciences 97:16, pages 9042-9046.
Crossref
Crossref
Wen Xie, Reqin Duan, Ichen Chen, Ismael Samudio & Stephen Safe. (2000) Transcriptional Activation of Thymidylate Synthase by 17β-Estradiol in MCF-7 Human Breast Cancer Cells*. Endocrinology 141:7, pages 2439-2449.
Crossref
Crossref
Nandini Ghosh-Choudhury, Goutam Ghosh-Choudhury, Anthony Celeste, Paramita M. Ghosh, Marissa Moyer, Sherry L. Abboud & Jeffrey Kreisberg. (2000) Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1497:2, pages 186-196.
Crossref
Crossref
Nandini Ghosh-Choudhury, Kathleen Woodruff, Wenbo Qi, Anthony Celeste, Sherry L. Abboud & Goutam Ghosh Choudhury. (2000) Bone Morphogenetic Protein-2 Blocks MDA MB 231 Human Breast Cancer Cell Proliferation by Inhibiting Cyclin-Dependent Kinase-Mediated Retinoblastoma Protein Phosphorylation. Biochemical and Biophysical Research Communications 272:3, pages 705-711.
Crossref
Crossref
Harikrishna Nakshatri, Marc S. Mendonca, Poornima Bhat-Nakshatri, Nikhil M. Patel, Robert J. GouletJr.Jr. & Kenneth Cornetta. (2000) The Orphan Receptor COUP-TFII Regulates G2/M Progression of Breast Cancer Cells by Modulating the Expression/Activity of p21WAF1/CIP1, Cyclin D1, and cdk2. Biochemical and Biophysical Research Communications 270:3, pages 1144-1153.
Crossref
Crossref
Canan G. Nebigil, Jean-Marie Launay, Pierre Hickel, Claire Tournois & Luc Maroteaux. (2000) 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross-talk with tyrosine kinase pathways. Proceedings of the National Academy of Sciences 97:6, pages 2591-2596.
Crossref
Crossref
Dezhong J Liao, Geraldine Natarajan, Sandra L Deming, M Hunter Jamerson, Michael Johnson, Gloria Chepko & Robert B Dickson. (2000) Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis. Oncogene 19:10, pages 1307-1317.
Crossref
Crossref
Isabelle Truchet, Suzanne Jozan, Marina Guerrin, Laurent Mazzolini, Simone Vidal & Annie Valette. (2000) Interconnections between E2-Dependent Regulation of Cell Cycle Progression and Apoptosis in MCF-7 Tumors Growing on Nude Mice. Experimental Cell Research 254:2, pages 241-248.
Crossref
Crossref
Qun Zhou, Julia Wulfkuhle, Taoufik Ouatas, Paula Fukushima, Maryalice Stetler-Stevenson, Fred R. Miller & Patricia S. Steeg. (2000) Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity. Breast Cancer Research and Treatment 59:1, pages 27-39.
Crossref
Crossref
Giovanna M. Ledda-Columbano, Monica Pibiri, Roberto Loi, Andrea Perra, Hisashi Shinozuka & Amedeo Columbano. (2000) Early Increase in Cyclin-D1 Expression and Accelerated Entry of Mouse Hepatocytes into S Phase after Administration of the Mitogen 1,4-Bis[2-(3,5-Dichloropyridyloxy)] Benzene. The American Journal of Pathology 156:1, pages 91-97.
Crossref
Crossref
Angel Wai-mun Lee, Sundaram Nambirajan & John G Moffat. (1999) CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells. Oncogene 18:52, pages 7477-7494.
Crossref
Crossref
A.S Lundberg & R.A Weinberg. (1999) Control of the cell cycle and apoptosis. European Journal of Cancer 35:14, pages 1886-1894.
Crossref
Crossref
Rosemary B. Duda, Ying Zhong, Vinicio Navas, Michael Z. C. Li, Brian R. Toy & Juan G. Alavarez. (1999) American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. Journal of Surgical Oncology 72:4, pages 230-239.
Crossref
Crossref
Akira OrimoSatoshi InoueOsamu MinowaNobuko TominagaYasuhiro TomiokaMiyuki SatoJunko KunoHisahiko HiroiYoshihiko ShimizuMasami SuzukiTetsuo NodaMasami Muramatsu. (1999) Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor α. Proceedings of the National Academy of Sciences 96:21, pages 12027-12032.
Crossref
Crossref
Xiaomei Chen, Michael Lowe & Khandan Keyomarsi. (1999) UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent. Oncogene 18:41, pages 5691-5702.
Crossref
Crossref
René Bernards. (1999) CDK-independent activities of D type cyclins. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1424:2-3, pages M17-M22.
Crossref
Crossref
Weili Wang, Lian Dong, Brad Saville & Stephen Safe. (1999) Transcriptional Activation of E2F1 Gene Expression by 17β-Estradiol in MCF-7 Cells Is Regulated by NF-Y-Sp1/Estrogen Receptor Interactions. Molecular Endocrinology 13:8, pages 1373-1387.
Crossref
Crossref
Richard G. PestellChris AlbaneseAnne T. ReutensJeffrey E. SegallRichard J. LeeAndrew Arnold. (1999) The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation*. Endocrine Reviews 20:4, pages 501-534.
Crossref
Crossref
R. J. Michalides. (1999) Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. Journal of Clinical Pathology 52:8, pages 555-568.
Crossref
Crossref
Te-Hsiu Lee, Lea-Yea Chuang & Wen-Chun Hung. (1999) Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells. Oncogene 18:29, pages 4269-4274.
Crossref
Crossref
Jiri Lukas, Claus S Sørensen, Claudia Lukas, Eric Santoni-Rugiu & Jiri Bartek. (1999) p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene 18:27, pages 3930-3935.
Crossref
Crossref
Guan Chen & Masahiro Hitomi. (1999) Dissociation of CDK2 from Cyclin A in Response to the Topoisomerase II Inhibitor Etoposide in v-src-Transformed but Not Normal NIH 3T3 Cells. Experimental Cell Research 249:2, pages 327-336.
Crossref
Crossref
Adrian V. Lee, James G. Jackson, Jennifer L. Gooch, Susan G. Hilsenbeck, Ester Coronado-Heinsohn, C. Kent Osborne & Douglas Yee. (1999) Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo. Molecular Endocrinology 13:5, pages 787-796.
Crossref
Crossref
R.A. Weinberg & A.S. Lundberg. (1999) Control of the cell cycle and apoptosis. European Journal of Cancer 35:4, pages 531-539.
Crossref
Crossref
Richard J. Lee, Chris Albanese, Robert J. Stenger, Genichi Watanabe, Giorgio Inghirami, George K. HainesIIIIII, Marc Webster, William J. Muller, Joan S. Brugge, Roger J. Davis & Richard G. Pestell. (1999) pp60v- Induction of Cyclin D1 Requires Collaborative Interactions between the Extracellular Signal-regulated Kinase, p38, and Jun Kinase Pathways. Journal of Biological Chemistry 274:11, pages 7341-7350.
Crossref
Crossref
Cliff Hurd, Sumi Dinda, Nidhi Khattree & V K Moudgil. (1999) Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Oncogene 18:4, pages 1067-1072.
Crossref
Crossref
Weili Wang, Roger SmithIIIIII & Stephen Safe. (1998) Aryl Hydrocarbon Receptor-Mediated Antiestrogenicity in MCF-7 Cells: Modulation of Hormone-Induced Cell Cycle Enzymes. Archives of Biochemistry and Biophysics 356:2, pages 239-248.
Crossref
Crossref
Owen W.J Prall, Eileen M Rogan & Robert L Sutherland. (1998) Estrogen regulation of cell cycle progression in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 65:1-6, pages 169-174.
Crossref
Crossref
Carolyn M. Cover, S. Jean Hsieh, Susan H. Tran, Gunnell Hallden, Gloria S. Kim, Leonard F. Bjeldanes & Gary L. Firestone. (1998) Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling. Journal of Biological Chemistry 273:7, pages 3838-3847.
Crossref
Crossref